1. TMDX faces class action allegations of fraud and misconduct. 2. Claims include kickbacks and safety oversight issues. 3. Shareholders are encouraged to register by April 15, 2025. 4. False statements may have inflated TMDX’s stock value. 5. Legal risk could impact investor confidence and stock performance.
The allegations indicate widespread fraud and safety issues, similar to past cases (such as Theranos). Companies facing such severe claims often see significant stock declines as investor confidence erodes.
The class action directly relates to TMDX's business practices, potentially affecting stock value significantly. The nature of the allegations raises serious concerns about management integrity and operational viability.
Legal ramifications and ongoing investigations can affect TMDX for years. Historical cases, like those of HealthSouth, show long-lasting impacts from fraud allegations.
The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. (NASDAQ: TMDX).
Shareholders who purchased shares of TMDX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE: Link
February 28, 2023 to January 10, 2025
The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue; (2) TransMedics engaged in unsafe practices and hid safety issues and generally lacked safety oversight; (3) the foregoing subjected TransMedics to heightened risk of scrutiny and regulatory risk; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
April 15, 2025. Shareholders should not delay in registering for this class action. Register your information here: Link
Once you register as a shareholder who purchased shares of TMDX during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 15, 2025. There is no cost or obligation to you to participate in this case.
The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: info@grosslawfirm.com
Phone: (646) 453-8903
SOURCE The Gross Law Firm